Bayer’s Diane-35 (cyproterone
acetate/ethinylestradiol) will be
reintroduced to the French market.
Withdrawn after a suspension
on 21 May 2013, the European
Medicines Agency (EMA) conducted
a review of the benefit-risk profile
and concluded the benefits
outweighed the risks, Bayer said.
The suspension had followed
French regulator ANSM’s statement
that 4 deaths due to thrombosis
were linked to the drug’s use over
25 years Reuters reported.
Bayer said it had been liasing
with the TGA in Australia about the
drug and had advised them of the
positive outcome in Europe.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jan 14
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.